Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Protara Therapeutics Inc. TARA

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).


Top institutional share ownership of ArTara Therapeutics, Inc.

Name Shares Shares % change Value Value % change
Opaleye Management Inc. 2,684,167 0.4% $8,885 -35.0%
Orbimed Advisors Llc 830,641 0.0% $2,434 -42.7%
Vanguard Group Inc 427,404 0.0% $1,253 -42.6%
Perceptive Advisors Llc 290,051 -24.4% $850 -56.6%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 284,301 0.0% $833 -42.6%
Ikarian Capital, LLC 257,853 -13.0% $756 -50.1%
Citadel Advisors Llc 242,571 -40.3% $711 -65.8%
Boxer Capital, LLC 209,227 0.0% $613 -42.7%
Baker Bros. Advisors Lp 199,671 0.0% $585 -42.7%
DLD Asset Management, LP 157,349 -31.5% $461 -60.7%

Top institutional buyers of ArTara Therapeutics, Inc.

Name Shares % change Value % change Shares Value
Renaissance Technologies Llc 44.2% -17.2% 54,200 $159
Assenagon Asset Management S.A. 33.5% -23.7% 58,389 $171
Geode Capital Management, Llc 2.1% -41.4% 83,644 $245
Opaleye Management Inc. 0.4% -35.0% 2,684,167 $8,885

Top institutional sellers of ArTara Therapeutics, Inc.

Name Shares % change Value % change Shares Value
Citadel Advisors Llc -40.3% -65.8% 242,571 $711
Two Sigma Investments, Lp -39.7% -65.4% 53,548 $157
DLD Asset Management, LP -31.5% -60.7% 157,349 $461
Perceptive Advisors Llc -24.4% -56.6% 290,051 $850
Two Sigma Advisers, Lp -19.4% -53.7% 53,118 $156
Millennium Management Llc -16.0% -51.9% 60,784 $178
Ikarian Capital, LLC -13.0% -50.1% 257,853 $756
Boothbay Fund Management, Llc -7.0% -46.8% 25,666 $75
Dimensional Fund Advisors Lp -6.2% -46.2% 28,700 $84
BlackRock Inc. -1.1% -43.5% 38,508 $113

Information provided by Fintel.io